Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
Meeting ReportOncology: Clinical Therapy and Diagnosis

Combined diagnostic value of 11C-methionine PET and 1H-MRS for gliomas

Xiaobin Zhao, Xin wang and Lin Ai
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 1296;
Xiaobin Zhao
1Beijing tiantan hospital BEIJING China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xin wang
1Beijing tiantan hospital BEIJING China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lin Ai
1Beijing tiantan hospital BEIJING China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

1296

Purpose: To identify the role of 11C-methionine (11C-MET) PET and proton MR spectroscopy (1H-MRS) in diagnosing clinically suspected gliomas and to assess the combined diagnostic value of 11C-MET PET and 1H-MRS in gliomas.

Methods: A total of 48 patients (female 17, male 31, mean age ± SD, 43 ± 15 y) with clinically suspected glioma were enrolled in this retrospective study. The participants underwent 11C-MET PET/CT and 1H-MRS within a month. 11C-MET PET/CT Semiquantitative-parameters of the maximum lesion-to-normal ratio (LNRmax) and 1H-MRS data of ratio of choline to N-acetyl-aspartate (Cho/NAA) were applied in differentiating gliomas from non-neoplastic lesions (NNLs) and glioma WHO grade. 1H-MRS was considered as tumor if the Cho/NAA ratio was greater than 1.

Results: There were 21 low-grade gliomas (LGGs), 14 high-grade gliomas (HGGs) among gliomas. And NNLs included 7 cases of demyelination, 2 cases of hemorrhagic necrosis, 1 cases of parasitic infections, 1 case of viral encephalitis, 1 case of epidermoid cyst. Glioma showed significant higher LNRmax than NNLs (3.5 ± 1.4 vs 1.7 ± 0.5, p < 0.05). The optimal thresholds of LNRmax for differentiating glioma from NNLs was 2.5. Sensitivity and specificity in the discrimination were 74.3%, 92.3% for LNRmax of 11C-MET PET and 57.1%, 46.2% for Cho/NAA of MRS. While sensitivity and specificity were 88.6%, 100% for combined evaluation of 11C-MET PET and MRS. There were no significant differences between LGGs and HGGs for LNRmaxand Cho/NAA (p = 0.159 and p = 0.099, respectively).

Conclusions: 1H-MRS can provide a complementary information for glioma diagnostic of 11C-MET PET.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 61, Issue supplement 1
May 1, 2020
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Combined diagnostic value of 11C-methionine PET and 1H-MRS for gliomas
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Combined diagnostic value of 11C-methionine PET and 1H-MRS for gliomas
Xiaobin Zhao, Xin wang, Lin Ai
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 1296;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Combined diagnostic value of 11C-methionine PET and 1H-MRS for gliomas
Xiaobin Zhao, Xin wang, Lin Ai
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 1296;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology: Clinical Therapy and Diagnosis

  • Added value of single photon emission computed tomography (SPECT) / Computed Tomography (CT) with radioiodine whole body scan in follow up of patients with differentiated thyroid cancer
  • Assessment of incidental pituitary uptake on FDG PET/CT scan: Digital vs. conventional PET/CT
  • Thyroglobulin measurement in fine-needle aspiration optimize lateral neck dissection in patients with papillary thyroid cancer
Show more Oncology: Clinical Therapy and Diagnosis

Head and Neck (Poster Session)

  • Prognostic value of tumor metabolic imaging phenotype using FDG PET radiomics in HNSCC
  • Clinical Factors affecting lithium carbonate in prolonging the effective half-life of 131I in patients’thyroid with hyperthyroidism
  • Assessment of incidental pituitary uptake on FDG PET/CT scan: Digital vs. conventional PET/CT
Show more Head and Neck (Poster Session)

Similar Articles

SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire